|
Environmental Genome Project top | ||
PROGRESSIVE | REFERENCE | CONSERVATIVE* |
|
||
GMO crops top | ||
PROGRESSIVE | REFERENCE | CONSERVATIVE* |
|
|
|
|
||
GMO Labeling top | ||
PROGRESSIVE | REFERENCE | CONSERVATIVE* |
|
|
|
Human Genome Project top | ||
PROGRESSIVE | REFERENCE | CONSERVATIVE* |
|
|
|
Insects, GMO top | ||
PROGRESSIVE | REFERENCE | CONSERVATIVE* |
|
|
|
Pharmacogenetics top | ||
PROGRESSIVE | REFERENCE | CONSERVATIVE* |
|
|
Baycol Watchdog
List of Genome Databases
Nucleotide Sequence Data Bases:
GenBank -
Nucleotide Sequence DB (NCBI, USA)
EMBL-DB (European Bioinformatics Institute, UK)
DDBJ - DNA Data Bank of Japan (National Institute of Genetics, Japan)
GDB - Genome Data Base at
Johns Hopkins University (USA).
OMIM - Online Mendelian Inheritance of Man - This catalog of human genes and
genetic diseases authored and edited by Victor A. McKusick contains textual and
reference information provided by NCBI
server (USA).
A Gene Map of the Human Genome is created by an international consortium to
map gene-based sequence tagged site markers on a set of a two radiation hybrid
panels and a YAC library.
The Human Transcript Map
Electronic version of the
Science wall chart summarizing over 16,000 human genes that have been mapped
relative to a framework map that contains about 1000 polymorphic genetic
markers.
Human Genome Sequence Data at HGC
(Berkeley Lab., USA)
GENETHON (GENETHON Genome Center, France)
GENATLAS in
INFOBIOGEN (France)
IMGT - ImMunoGeneTics Database (France)
HUGEN - Human Gene Encyclopedia at EIMB
- Engelhardt Institute of Molecular Biology (Moscow, Russia).
TIGR Human Gene Index integrates research results from international human
EST and gene research projects, and represents a non-redundant view of human
genes. The Institute of Genomic Research
located in Washington DC provides details of its genome sequencing projects and
genetics resources.
Human Gene Mutation Database - Information on known gene lesions responsible
for human inherited diseases, searchable by disease or gene name.
University of Wales - College of Medicine
(Cardiff, UK)
GeneCards Project
Bioinformatics Unit, Genome Center and Weizmann Institute of Science
(Israel)
KEGG - Kyoto Encyclopedia of Genes and Genomes
The Kanehisa laboratory (in
the Institute for Chemical Research,
Kyoto University) and the
Human Genome Center (in the
Institute of Medical Science,
University of Tokyo, Japan)
LDB - The Location Database is a database for constructing fully integrated
genetic and physical maps. The ldb program generates an integrated map (known as
the summary map) from partial maps of physical, genetic, regional, mouse
homology and cytogenetic data. (Genetic
Epidemiology Group of University of Southampton, UK)
STS table and physical maps (5q) from LBNL
- Lawrence Berkeley National Laboratory Genome Center (USA)
IMGT - Immunogenetics Database from EBI
- European Bioinformatics Institute (UK)
Transcription Factor Database at ICIG
(Novosibirsk, Russia) and at GBF-Braunsweig
(Germany)
Transcription Region Database at ICIG
(Novosibirsk, Russia)
Transcriptional Regulation of Oncogenes at
ICIG (Novosibirsk, Russia)
RHDB - Radiation Hybrid Database from EBI
- European Bioinformatics Institute (UK)
Restriction Enzyme Database (REBASE)
Codons for nuclear genes
Estimated sizes for
human chromosomes
A database of human
repeated DNA
at Virtual Genome Center
Protein Databases and Servers
-Protein Information Resources (UK)
PIR - Protein Information Resource (USA)
OWL - Composite Protein Sequence Database (UK)
PDB - Protein Data Bank (USA) - is an archive of experimentally determined
three-dimensional structures of biologically macromolecules.
Kabat Database of Proteins of Immunological Interest (USA)
Protein Research Foundation - PRF (Japan)
HotMolecBase (Israel) QUEST Protein Database Center (USA)
Structural Classification of Proteins (SCoP) (UK)
ProDom Protein Domain Database
PROLYSIS - protease and protease inhibitors (Univ. of Tours, France)
SWISS-PROT is a curated protein sequence database which strives to provide a
high level of annotations (such as the description of the function of a protein,
its domains structure, post-translational modifications, variants, etc), a
minimal level of redundancy and high level of integration with other databases (ExPASy,
Switzerland).
PROSITE - Dictionary of protein sites and patterns (ExPASy, Switzerland)
SWISS-2DPAGE - Two-dimensional polyacrylamide gel electrophoresis database (ExPASy,
Switzerland)
PUMA Database: Phylogeny, Metabolism, Alignments (Argonne National
Laboratory, USA)
SWISS-3DIMAGE - 3D images of proteins and other biological macromolecules (ExPASy,
Switzerland)
SWISS-MODEL Repository - A database of automatically generated protein
models (ExPASy, Switzerland)
ENZYME - Enzyme nomenclature database (ExPASy, Switzerland)
Other (non-Human) Genome Databases and Genome Project Servers
Agricultural Genome (National
Agricultural Library)
Arabidopsis Genome Database (AAtDB)
Arabidopsis thaliana Database Big Blue and MutaMouse Web Site
C. elegans Genome Database (ACeDB)
Integrated Genome Database (IGD)
Maize Genome Database (MaizeDB)
Mouse and Rat Research Home Page from Eric Mercer
Mouse Genome Informatics from Jackson Lab
(USA)
Mycobacterium Genome Database (MycDB)
Portable Dictionary of the Mouse Genome >Reference Library DataBase (RLDB2)
Saccharomyces Genomic Information Resource
TBASE - Transgenic and Targeted knockout mice database (at John Hopkins
Univ., USA)
Transgenic and Targeted Mutant Animal Database (at Oak Ridge)
Uncategorized links
Defense Technical Information Center
- Reports on DoD laboratory activites
All Russian Collection of Microorganisms (Puschino, Russia)
Paul N. Hengen's Home Page - Editor of biosci.methds-reagnts
Vector Database from Stephen Miseners
Return to the TOP of this Page
Last modified 26 March 2001 by
Bioinformatics Center : [email protected]
Genetically modified ‘frankenfish’ to appear in US stores |
RT Genetically modified ‘frankenfish’ to appear in US stores Get short URL email story to a friend print version Published: 22 December, 2012, 00:44 TAGS: Animals, SciTech, USA, Agriculture,Science Reuters/Ki Price Regulators with the FDA have released a preliminary report that suggests they will soon give the go-ahead to a team of scientists who’ve created a sci-fi “frankenfish.” On Friday, the US Food and Drug Administration released an environmental assessment report regarding a salmon-hybrid developed in the laboratories of AquaBounty. The FDA must wait two months before they make final their decision regarding the fate of the frankenfish, but through their study they have determined that the genetically engineered animal, the “AquAdvantage,” is safe enough to be sold. The fish, a hybrid of the Pacific Chinook salmon and a ray-finned creature called the eelpout, is engineered to grow twice as normal as traditional salmon. Once the frankenfish is approved for good, AquaBounty will be able to offer meatier fish able to feed more people. “In all other respects,” the company says the AquAdvantage fish is “identical to other Atlantic salmon.” The AquAdvantage "will not have any significant impacts on the quality of the human environment of the United States,” the FDA wrote, noting additionally that the fish is unlikely to harm populations of natural salmon. The FDA has 60 days to hear remarks from the public before it makes its final decision. At this point, though, experts weighing in with the Associated Press say the report suggests an approval is all but certain. From there, AquaBounty is likely to release what will be the first genetically engineered animal ever determined safe for human consumption. With no other such animal ever approved in the past, though, concerns have been plentiful over what consequences the creature could spawn. Bill Freese, a science policy analyst with the Center for Food Safety, told Women’s Health Magazine recently that while the FDA obviously has regulations the fish will have to pass, that process is “totally unlike” how the FDA goes about approving drugs. According to Freese, “a very lax regulatory system” could lead to dire results. “This is a radical new technology. We need very good, careful, close regulation, and we just don't have that. We can't be assured of the safety of any of these genetically engineered organisms,” he said. Developing the frankenfish has so far cost AquaBounty nearly two decades of research and tens of millions of dollars. Only weeks ago, though, the very fate of the fish was put at risk. While awaiting news from the FDA in early December, AquaBounty CEO Ron Stotish told the Associated Press that length delays had nearly drained the company from all their money. "It's threatening our very survival," Stotish told the AP. "We only have enough money to survive until January 2013, so we have to raise more. But the unexplained delay has made raising money very difficult." In 2010, the FDA concluded that the AquaAdvantage fish was just as safe as traditional salmon to eat. Only now, however, has it been finally able to release its environmental assessment report, one of the final steps before AquaBounty can be given the green light. |
newsfollowup.com